Abstract 1 2
Background: Antimicrobial peptides (AMP) are widely recognized as promising 3 alternatives to the current use of antibiotics and fungicides. Amino acid 4 sequences of a vast majority of AMP share cationic and amphipathic 5 biophysical properties that allow their insertion into lipid bilayers, and can lead 6 to alteration of biological membrane functions. Initial characterization studies 7 linked these properties to antimicrobial killing activity. However, additional data 8 indicate that this is not the sole mode of action and that more subtle 9 mechanisms might mediate the interaction with and effect to target microbes, as 10 well as the specificity and toxicity of peptides. As such, antimicrobial peptides 11 are increasingly viewed as powerful multifunctional drugs. characterized from a vast number of organisms, from bacteria to insects, plants 4
and humans [1] . The increasing problem of antibiotic resistance in clinic [2, 3] acid residues in some synthetic peptides to about 50 -and even up to 100-in 20 natural ones; most of them (although not all) are cationic having positive charge 21 at physiological conditions due to the presence of arginine and lysine residues, 22 also have a high proportion (up to 50%) of hydrophobic residues, and are 23 capable to fold or arrange into a variety of amphipathic structures and 24 conformations. Cationic charge and amphipathic arrangement are on the basis 25 of their propensity of in vitro interaction with anionic lipid bilayers. In fact, initial 1 studies after discovery of the first AMP were coincident in concluding that 2 antimicrobial activity was a primary consequence of the capacity of cationic 3 amphipathic peptides to interact and disrupt biological membranes, thus 4 resulting in direct cell killing. Treatment of microorganisms with above minimal 5 inhibitory AMP concentration resulted in microbial cell permeation that 6 correlated with microbicidal potency. As consequence, many of the 7 contributions that dealt with AMP mechanism relied on models of peptide 8 interaction with -and disruption of-lipid bilayers. 9 
10
However, a key weakness point was that AMP cationic charge led to the early 11 recognition that salts -at concentrations close to physiological-blocked AMP 12 interaction with negatively charged microbe surface groups, and also 13 diminished the in vitro inhibitory activity of microorganism growth. It was difficult 14 to reconciliate this apparent limitation with the evidence that the high number 15 and diversity of AMP in living organisms is indicative of an important 16 physiological role, presumably in host defense. 17 
18
A way out of this dilemma derives from the recognition of multilayer roles of 19 peptides in the regulation of host response, also acting on specific cells as 20 effectors of the adaptive immune system [8] . Representative examples are 21 human defensins and the cathelicidin LL-37 [9, 10] . In particular, human 22 defensins have emerged as an evolutionary link that bridges innate and 23 adaptive immune responses [10] . But there are also additional alternatives to 24 justify the prevalence of AMP in nature. 25 
1
If specific AMP can participate in complex processes such as regulation of the 2 mammal immune response, it is not senseless that can also exert multifaceted 3 lethal actions on microbes. In fact, alternative mechanisms have been 4 increasingly considered as part of AMP action against microbes [11] [12] [13] . 5
Reports have analyzed peptide action towards microbes (not under in vitro 6 membrane mimicking lipid environments) in greater detail, and accumulated 7 convincing evidence that specific peptides do not exert antimicrobial activity by 8 primarily permeabilizing cell membranes. Among these are apidaecin [14] or 9 dermicidin [15] acting on bacterial cells, and specific human defensins and 10 histatin-5 [16, 17] or synthetic peptides [18, 19] on fungal cells. Therefore, 11 alternative non-lytic modes of action are recognized. Recent reviews have 12 addressed this question in the case of antibacterial peptides [20, 21] or the 13 antifungal action of defensins [22] . This contribution aims to provide an updated 14 and broader view to these alternative AMP modes of action or interactions with 15 microbes, to the approaches to further investigate the extent and significance of 16 these, as well as to discuss how this knowledge can be incorporated to the 17 design of novel and improved AMP with higher antimicrobial potency and lower 18 unspecific toxicity. The use of (model) microorganisms for which genomic-scale 19 tools are available and the identification of genes that modulate the microbial 20 susceptibility will be pivotal in the understanding of peptide antimicrobial action. 21 We will not address, however, the responses of microbes to counteract peptide 22 action, that recent reviews summarize in detail [23] . 23 24 3. Interaction with microbial surface. 25 
Before reaching cell membranes, the first layer of contact for surrounding 2 peptides is the outer microbial surface. There was no evidence of specific and 3 canonical receptors linked to the interaction of peptides with target 4 microorganism and microbial killing. Early reports on the similar activity of 5 stereoisomeric AMP sustained the conclusion that interaction was not stereo-6 specific [24] . Recently, non-chiral interaction has even been shown for peptides 7 acting intracellularly [25] . However, there were also examples for which 8 stereospecificity was shown [26] , and in some cases correlated with an 9 antimicrobial mechanism that was not pore-forming [14] . In addition to electrostatic attraction, specific cell membrane/wall components 24 have been shown to promote the interaction with peptides. A significant 25 example is the antibacterial peptidic lantibiotic nisin, for which it is established 1 that the membrane-bound peptidoglycan precursor Lipid II acts as a docking 2 moiety to attract the peptide to the bacterial membrane and promote peptide 3 insertion into membrane and cell permeation [34] [35] [36] . Interestingly, nisin is 4 active at nanomolar range against bacteria containing Lipid II, roughly three 5 orders of magnitude more active than peptides that only act through 6 permeation. Nisin is not active against yeast or filamentous fungi; however, 7 yeast spheroplasts are rapidly lysed when incubated in the presence of nisin at 8 concentrations which do not affect intact cells [37] . This latter activity is 9 presumed to be a consequence of the intrinsic capacity of nisin to disturb lipid 10 bilayers. Thus, even in the case of true membrane-perturbing peptides, 11 additional factors such as their propensity to interact with specific compounds 12 might modulate (and enhance) their (membrane) activity. Interestingly, the 13 related peptidic lantibiotic mersacidin also binds Lipid II, albeit at its terminal N-14 acetylglucosamine, and inhibits bacterial growth with no cell permeation 15 [38, 39] . Because of these binding capacities nisin, as well as mersacidin, also 16 interfere with the peptidoglycan biosynthesis of bacterial envelope [35] (Table  17 1), being one clear example of multilayer actions among AMP. 18 
19
Nisin is a well known example, but analogous situations may occur with specific 20 defensins, whose antifungal activity is linked to the presence of distinct classes 21 of membrane glycolipids. Hence, the activity of the plant defensin DmAMP1 and 22 the cyclic lipopeptide syringomycin E are dependent on the biosynthesis of the 23 acidic sphingolipid mannosyl diinositolphosphoryl ceramide, since the presence 24 of functional IPT1 and SKN1 genes were linked to an enhanced resistance 25 potential targets for selective antifungals [50] [51] [52] [53] [54] . It would be desirable the 1 detailed characterization of the interaction of selected AMP with such glycan 2 structures, in order to obtain information on both the potential microbial targets 3 and the peptide structural requirements for activity. 4 5 Additional studies report on the involvement of cell wall proteins on the fungal 6 susceptibility to AMP. In several examples, the relevance of specific cell wall 7 proteins is likely due to a general strengthening of cell wall that increases 8 thickness or reinforces its structural resistance after exposure to peptides, as is 9 the case of yeast PIR proteins in the interaction with tobacco osmotin [55] or 10 other CWP proteins with nisin [37] . 11
12
A remarkable example studied in detail is that of SSA1 and SSA2, cell surface 13 proteins from Candida that mediate the activity of distinct AMP as human β- as an inhibitor of the activity of a yeast plasma membrane ATPase (Pma1) that 4 impairs in vitro growth with no permeation at growth-inhibitory concentrations 5 [18] . The peptide locates and is reported to be active at the cell surface. in a non-disruptive mechanism, and examples exist in bacteria and fungi. Insect 16 apidaecin was one of the first AMP for which a non-pore forming mechanism 17 was invoked [14] , and early uptake assays with radiolabeled peptide indicated 18 retention by E. coli cells [82] . The use of fluorescently labeled peptides and 19 proteins coupled to confocal microscopy has boosted the demonstration of cell 20 internalization of this and other AMP [19, 46, [83] [84] [85] [86] [87] [88] [89] . Additional techniques such 21 as immunodetection were used to show that antimicrobial proteins enter fungal 22 hyphae [87] . In several of these reports, peptide internalization was shown at 23 peptide concentrations and/or times of exposure at which no obvious growth 24 alteration or cell membrane damage could be observed. For instance, the 25 synthetic hexapeptide PAF26 was internalized at sub-inhibitory concentrations 1 by fungal hyphae and caused severe morphological alterations in the absence 2 of mycelium permeation, which was finally produced at higher completely 3 inhibitory concentrations [19] . Another noteworthy example is that of the 4 synthetic NK-2 peptide, which is selectively internalized by Plasmodium infected 5 red blood cells due to the increase in the negative charge of the membrane that 6 occurs in infected cells, and subsequently kills the protozoan pathogen 7 intracellulary [90] . 8 9 Targeting of peptides to specific cell compartments has also been shown and in 10 some cases linked to the antimicrobial activity. Thus, the pea defensin PSD1 11 was shown to locate inside the nucleus of the model fungus Neurospora crassa, 12
wherein it might alter cell cycle progression [46] . Also, histatin-5 at low (inactive) 13 concentrations is directed towards yeast vacuoles, while inhibitory higher 14 concentrations locate in the cytosol [17] . 15 16 A paradigmatic example of cell penetration is that of antimicrobial peptides 17 derived from bovine lactoferrin, which have been shown to be internalized by 18 both bacterial and yeast cells [86, 91] . It remains to be determined, however, 19 whether cell internalization share common mechanism for both classes of 20 microorganisms. 21 
22
The capability to penetrate target cells is therefore increasingly viewed as a 23 common property of distinct cationic AMP (Table 1) The use of genomic tools is expected to help in the characterization of 6 alternative modes of AMP action, including the effects on microorganisms, the 7 determinants of susceptibility to peptide action and the identification of potential 8 microbial targets. These approaches will lead to the identification of microbial 9 genes that modulate sensitivity to peptides (Table 2) and screening/selection of collections of mutants will be pivotal to unravel the 2 mechanism of action of selected peptides. We have given some relevant 3 examples of this [61,64,106], but they are still scarce. These types of studies 4 are identifying relevant genes modulating sensitivity to AMP (Table 2) . With an 5 increasing number of reports we will be in good position to ask the fundamental 6 question on whether there are non-lytic modes of AMP action "common" to 7 distinct peptides and whether each peptide class has specific properties not 8 shared by others. Also related, we will be able to classify AMP in relation to their 9 effect on target cells, as well as to identify those cell targets that are more 10 promising in terms of potency and specificity. 11
12
The use of synthetic peptides and their sequence analogs will be critical in 13 establishing structure/activity relationships between peptide sequence, 14 antimicrobial activity and effects on microorganisms, with the potential for 15 extrapolation to the genetic/molecular determinants of peptide susceptibility of 16 the latter. It is intriguing, for instance, that highly related plant defensins seem to 17 interact with distinct cell components/signaling cascades [43, 73] . A 18 consequence is that minor amino acid changes in AMP could be responsible for 19 differences in the specific modes of action [35, 57] . Due to their small size and 20 feasibility of synthetic production, small AMP can be used to dissect the 21 molecular basis of such differences and specificities. • Demonstration of the linkage between the RNase activity of a plant PR10 37 and its antimicrobial properties; these latter require, although are not 38 linked to, internalization into fungal cells. 39 
